Taysha Gene Therapies
TSHA
TSHA
51 hedge funds and large institutions have $475M invested in Taysha Gene Therapies in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$38M | |
| 2 | +$10.3M | |
| 3 | +$10.3M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.35M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.92M |
Top Sellers
| 1 | -$8.37M | |
| 2 | -$5.56M | |
| 3 | -$5.27M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.96M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$4.48M |